Skip to main content

Table 5 Detailed outcome statistics for opiate free success for selected treatment variables

From: Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program

  Median Mean Std. Dev. % Completed % Censored Total N
No. Detox's       
1 15.29 23.09 24.64 38.74 61.26 222
2 55.00 53.82 30.07 35.38 64.62 65
3 55.00 61.43 30.00 40.00 60.00 45
4 76.86 78.56 35.66 30.77 69.23 13
5 66.86 78.19 34.35 18.18 81.82 11
6 95.29 95.66 21.45 25.00 75.00 8
7 126.64 126.64 1.92 50.00 50.00 2
Total 25.00 39.04 34.45    366
No. Implants       
0 27.29 40.22 35.73 46.72 53.28 274
Single 16.29 28.32 27.57 18.18 81.82 77
Multiple 57.71 56.07 32.49 8.00 92.00 25
Total 25.00 38.84 34.57    376
Type of Treatment       
Historicals 56.86 48.83 36.94 55.28 44.72 161
Tablets 21.57 27.96 30.06 34.51 65.49 113
USA 17.14 30.59 28.68 16.67 83.33 78
Perth 51.36 49.84 34.56 12.50 87.50 24
Total 25.00 38.84 34.57    376
Urinary Naltrexone       
Absent 36.00 43.48 36.33 47.06 52.94 85
UDS + 30.14 43.75 35.95 27.54 72.46 69
UDS ++-++++ 24.00 37.96 32.76 27.93 72.07 111
Total 27.29 41.24 34.75    265
  1. Note on Table interpretation. The first three columns of this table list the days of opiate free success. "Completed" observations refers to patients whose clinical course has been determined be there time of follow-up. Censored observations refer to those patients still in treatment at the time of follow-up, and whose final outcome in treatment therefore remains to be determined at a future time point.